317 filings
Page 7 of 16
8-K
zhv723q
11 Oct 16
Other Events
12:00am
8-K
r4q0mmb9mdx cd
8 Sep 16
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2017 and Recent Developments
12:00am
8-K
a1hv4k 7q
6 Sep 16
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible
12:00am
8-K
3sy ssqezszfc59w3yj5
14 Jul 16
Results of Operations and Financial Condition
12:00am
8-K
kvx8q
3 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
8nltu 7gts81qeq
2 Jun 16
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible
12:00am
8-K
o5rl64r
2 Jun 16
Other Events
12:00am
8-K
mz7mi9aob 5yjshqdvwb
12 Apr 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
quobite
17 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
m7il6 6xy
9 Mar 16
Peregrine Pharmaceuticals Reports Financial Results for Third Quarter of Fiscal Year 2016 and Recent Developments
12:00am
8-K
bfb6vctwnff5zmku2 9r
7 Mar 16
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
12:00am
8-K
ehy4b 5mxdbw01
26 Feb 16
Peregrine Pharmaceuticals Provides Update on PHASE III SUNRISE Trial of Bavituximab
12:00am
8-K
jn1zpec4r
10 Dec 15
Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2016 and Recent Developments
12:00am
8-K
ybfwm
7 Dec 15
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible
12:00am
8-K
e6anobuezajj bmu8c
30 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
aypphw 1djg876plqj
16 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
wgnet8jw
15 Oct 15
Other Events
12:00am
8-K
aqotcdyerj76lpz4l
9 Sep 15
Results of Operations and Financial Condition
12:00am
8-K
0simd1
8 Sep 15
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E
12:00am
8-K
vzuak7v7c u0yc
24 Aug 15
Other Events
12:00am